title: To maintain or not, that is the question.
authors.affiliation: Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.
authors.forename: Paw
authors.identifier: 0000-0002-5248-0523
authors.initials: P
authors.lastname: Jensen
authors.affiliation: Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.|Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
authors.forename: Mette D
authors.initials: MD
authors.lastname: Bendtsen
authors.affiliation: Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.|Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
authors.forename: Hans E
authors.initials: HE
authors.lastname: Johnsen
authors.affiliation: Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.|Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
authors.forename: Martin
authors.initials: M
authors.lastname: Bøgsted
authors.affiliation: Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark. tarec.galaly@gmail.com.|Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. tarec.galaly@gmail.com.
authors.forename: Tarec C
authors.initials: TC
authors.lastname: El-Galaly
mesh_terms: D003362:Cost-Benefit Analysis / Q000191:economics / Q000379:methods / Q000592:standards; D023381:Endpoint Determination / Q000191:economics; D017048:Health Care Costs / Q000331:legislation & jurisprudence / Q000592:standards / Q000639:trends*; D006801:Humans; D019057:Quality-Adjusted Life Years
keywords: cost benefit; malignant lymphomas; monoclonal antibodies